U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C28H30N2O2.BrH
Molecular Weight 507.462
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DARIFENACIN HYDROBROMIDE

SMILES

Br.NC(=O)C([C@@H]1CCN(CCC2=CC=C3OCCC3=C2)C1)(C4=CC=CC=C4)C5=CC=CC=C5

InChI

InChIKey=UQAVIASOPREUIT-VQIWEWKSSA-N
InChI=1S/C28H30N2O2.BrH/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26;/h1-12,19,25H,13-18,20H2,(H2,29,31);1H/t25-;/m1./s1

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
DARIFENACIN HYDROBROMIDE
EMA EPAR   JAN   MART.   MI   ORANGE BOOK   USAN   WHO-DD  
USAN  
Official Name English
DARIFENACIN HYDROBROMIDE [USP-RS]
Common Name English
DARIFENACIN HYDROBROMIDE [USAN]
Common Name English
3-PYRROLIDINEACETAMIDE, 1-(2-(2,3-DIHYDRO-5-BENZOFURANYL)ETHYL)-.ALPHA.,.ALPHA.-DIPHENYL-, MONOHBR, (3S)-
Common Name English
DARIFENACIN HYDROBROMIDE [JAN]
Common Name English
UK-88525-04 (HBR)
Common Name English
3-PYRROLIDINEACETAMIDE, 1-(2-(2,3-DIHYDRO-5-BENZOFURANYL)ETHYL)-.ALPHA.,.ALPHA.-DIPHENYL-, MONOHYDROBROMIDE, (3S)-
Common Name English
DARIFENACIN HYDROBROMIDE [MART.]
Common Name English
ENABLEX
Brand Name English
DARIFENACIN HYDROBROMIDE [EMA EPAR]
Common Name English
DARIFENACIN HYDROBROMIDE [ORANGE BOOK]
Common Name English
(S)-2-{1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidnyl}-2,2-diphenylacetamide hydrobromide
Common Name English
DARIFENACIN HBR
Common Name English
Darifenacin hydrobromide [WHO-DD]
Common Name English
EMSELEX
Brand Name English
UK-88525-04 (HYDROBROMIDE)
Code English
(S)-2-(1-(2-(2,3-DIHYDROBENZOFURAN-5-YL)ETHYL)-3-PYRROLIDNYL)-2,2-DIPHENYLACETAMIDE HBR
Common Name English
DARIFENACIN HYDROBROMIDE [MI]
Common Name English
Classification Tree Code System Code
EMA ASSESSMENT REPORTS EMSELEX (AUTHORIZED: URINARY BLADDER, OVERACTIVE)
Created by admin on Fri Dec 15 15:33:54 UTC 2023 , Edited by admin on Fri Dec 15 15:33:54 UTC 2023
EMA ASSESSMENT REPORTS EMSELEX (AUTHORIZED: URINARY INCONTINENCE, URGE)
Created by admin on Fri Dec 15 15:33:54 UTC 2023 , Edited by admin on Fri Dec 15 15:33:54 UTC 2023
NCI_THESAURUS C29704
Created by admin on Fri Dec 15 15:33:54 UTC 2023 , Edited by admin on Fri Dec 15 15:33:54 UTC 2023
Code System Code Type Description
EPA CompTox
DTXSID9046780
Created by admin on Fri Dec 15 15:33:54 UTC 2023 , Edited by admin on Fri Dec 15 15:33:54 UTC 2023
PRIMARY
SMS_ID
100000089583
Created by admin on Fri Dec 15 15:33:54 UTC 2023 , Edited by admin on Fri Dec 15 15:33:54 UTC 2023
PRIMARY
NCI_THESAURUS
C78068
Created by admin on Fri Dec 15 15:33:54 UTC 2023 , Edited by admin on Fri Dec 15 15:33:54 UTC 2023
PRIMARY
ChEMBL
CHEMBL1346
Created by admin on Fri Dec 15 15:33:54 UTC 2023 , Edited by admin on Fri Dec 15 15:33:54 UTC 2023
PRIMARY
CAS
133099-07-7
Created by admin on Fri Dec 15 15:33:54 UTC 2023 , Edited by admin on Fri Dec 15 15:33:54 UTC 2023
PRIMARY
DRUG BANK
DBSALT001041
Created by admin on Fri Dec 15 15:33:54 UTC 2023 , Edited by admin on Fri Dec 15 15:33:54 UTC 2023
PRIMARY
EVMPD
SUB21464
Created by admin on Fri Dec 15 15:33:54 UTC 2023 , Edited by admin on Fri Dec 15 15:33:54 UTC 2023
PRIMARY
MERCK INDEX
m4096
Created by admin on Fri Dec 15 15:33:54 UTC 2023 , Edited by admin on Fri Dec 15 15:33:54 UTC 2023
PRIMARY Merck Index
USAN
QQ-85
Created by admin on Fri Dec 15 15:33:54 UTC 2023 , Edited by admin on Fri Dec 15 15:33:54 UTC 2023
PRIMARY
FDA UNII
CR02EYQ8GV
Created by admin on Fri Dec 15 15:33:54 UTC 2023 , Edited by admin on Fri Dec 15 15:33:54 UTC 2023
PRIMARY
CHEBI
31455
Created by admin on Fri Dec 15 15:33:54 UTC 2023 , Edited by admin on Fri Dec 15 15:33:54 UTC 2023
PRIMARY
RXCUI
485417
Created by admin on Fri Dec 15 15:33:54 UTC 2023 , Edited by admin on Fri Dec 15 15:33:54 UTC 2023
PRIMARY RxNorm
RS_ITEM_NUM
1164200
Created by admin on Fri Dec 15 15:33:54 UTC 2023 , Edited by admin on Fri Dec 15 15:33:54 UTC 2023
PRIMARY
PUBCHEM
444030
Created by admin on Fri Dec 15 15:33:54 UTC 2023 , Edited by admin on Fri Dec 15 15:33:54 UTC 2023
PRIMARY
DAILYMED
CR02EYQ8GV
Created by admin on Fri Dec 15 15:33:54 UTC 2023 , Edited by admin on Fri Dec 15 15:33:54 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of DARIFENACIN
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966